시장보고서
상품코드
2035885

CRISPR 형광 분석 시장 보고서(2026년)

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Global Market Report 2026

발행일: | 리서치사: 구분자 The Business Research Company | 페이지 정보: 영문 250 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 4,490 금액 안내 화살표 ₩ 6,791,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 금액 안내 화살표 ₩ 9,816,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 금액 안내 화살표 ₩ 12,841,000
※ 부가세 별도
한글목차
영문목차

CRISPR 형광 분석 시장 규모는 최근 급성장하고 있습니다. 이 시장은 2025년 15억 7,000만 달러에서 2026년에는 18억 7,000만 달러로, CAGR 19.3%로 성장할 전망입니다. 지난 몇 년간의 성장 요인으로는 신속한 분자진단에 대한 수요 증가, Cas9 기반 검출 도구의 채택, 학술 및 연구 기관의 확대, 제약 및 생명공학 연구의 확대, 유전자 연구 이니셔티브의 확산 등이 있습니다.

CRISPR 형광 분석 시장 규모는 향후 몇 년간 급성장이 전망되고 있습니다. 2030년에는 38억 3,000만 달러에 이르고, CAGR은 19.5%를 보일 전망입니다. 예측 기간 동안 이러한 성장은 다중 및 하이스루풋 분석의 채택 확대, AI 지원 분석 플랫폼과의 통합 발전, 현장 진단에 대한 수요 증가, 임상 실험실의 기능 확장, 맞춤형 의료에 대한 관심 증가에 기인하는 것으로 분석됩니다. 예측 기간 동안 주요 동향으로는 다중 CRISPR 형광 분석의 채택 확대, Cas12 및 Cas13 기반 검출 기술에 대한 수요 증가, 실시간 형광 리더의 통합 확대, 진단 및 신약 개발 응용 분야 확대, 고감도 병원체 및 바이오마커 검출에 대한 관심 증가 등을 꼽을 수 있습니다.

맞춤형 의료에 대한 관심이 높아지면서 향후 몇 년 동안 CRISPR 형광 분석 시장의 성장을 견인할 것으로 예측됩니다. 맞춤형 의료란 개인의 유전적 구성, 환경적 요인, 생활습관 특성에 따라 의료 시술이나 예방 전략을 맞춤화하여 최대의 효과를 얻는 것을 말합니다. 맞춤형 의료의 확대는 만성질환 유병률 증가로 인해 더욱 가속화되고 있습니다. 만성질환은 기존 치료법에 비해 환자 개개인에게 더 나은 치료 결과를 가져다주는 표적치료제가 요구되고 있습니다. CRISPR 형광 분석은 환자의 DNA 내 유전자 돌연변이 및 바이오마커를 신속하고 특이적으로 식별할 수 있어 의사가 질병을 유발하는 돌연변이를 감지하고 환자별 유전자 프로파일에 따라 맞춤형 치료를 할 수 있도록 지원함으로써 맞춤형 의료를 뒷받침하고 있습니다. 예를 들어, 미국 비영리단체인 Personalized Medicine Coalition의 보고서에 따르면, 2024년 2월 현재 FDA는 2023년 16건의 희귀질환 환자를 위한 새로운 개인 맞춤형 치료제를 승인했으며, 이는 2022년 6건보다 증가한 수치입니다. 이는 2022년 6건에서 증가한 수치입니다. 그 결과, 맞춤형 의료에 대한 지지가 높아지면서 CRISPR 형광 분석 시장 확대에 기여하고 있습니다.

연구 개발 활동 증가는 향후 CRISPR 형광 분석 시장의 성장을 가속화할 것으로 예측됩니다. 연구개발(R&D) 활동은 혁신과 비즈니스 발전을 촉진하기 위해 새로운 지식, 제품 또는 프로세스를 창출하고 평가하는 것을 말합니다. 기업이 신규 및 개선된 제품 및 기술 개발을 통해 성장을 달성하고 경쟁 우위를 유지하기 위해 노력함에 따라 이러한 활동은 확대되고 있습니다. 연구 개발 노력은 분석 기술 향상, 검출 정확도 향상, 유전자 분석 및 표적 치료 응용을 위한 혁신적인 솔루션 개발을 통해 CRISPR 형광 분석법을 강화하고 있습니다. 예를 들어, 영국 정부 기관인 국가통계청(Office for National Statistics)에 따르면, 영국 정부의 연구개발(R&D) 순지출은 2022년 161억 파운드(204억 5,000만 달러)에서 2023년 174억 파운드(221억 달러)로 8.2% 증가할 것으로 예상하고 있습니다. 증가하여 8.2%의 성장을 보였습니다. 따라서 연구 개발 활동에 대한 관심이 높아지면서 CRISPR 형광 분석 시장의 성장을 주도하고 있습니다.

자주 묻는 질문

  • CRISPR 형광 분석 시장 규모는 어떻게 변화할 것으로 예상되나요?
  • CRISPR 형광 분석 시장의 성장 요인은 무엇인가요?
  • 맞춤형 의료가 CRISPR 형광 분석 시장에 미치는 영향은 무엇인가요?
  • 연구 개발 활동이 CRISPR 형광 분석 시장에 미치는 영향은 무엇인가요?
  • CRISPR 형광 분석 시장의 주요 동향은 무엇인가요?

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 시장 분석 : 최종 이용 산업별

제6장 시장 거시경제 시나리오(금리, 인플레이션, 지정학, 무역 전쟁 및 관세 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향 포함)

제7장 세계 시장 전략 분석 프레임워크, 현재 시장 규모, 시장 비교, 성장률 분석

제8장 세계의 총잠재 시장 규모(TAM) 분석

제9장 시장 구분

제10장 지역별/국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 주요 기업 및 혁신 기업

제38장 세계 시장 : 경쟁 벤치마킹과 대시보드

제39장 시장에 등장 예정 스타트업

제40장 주요 기업인수합병(M&A)

제41장 시장 잠재력 높은 국가, 부문 및 전략

제42장 부록

JHS

Clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays are molecular diagnostic tools that combine CRISPR-Cas systems with fluorescent reporters to detect specific DNA or RNA sequences. They facilitate rapid, sensitive, and precise detection of pathogens, genetic mutations, or biomarkers. These assays offer high specificity through CRISPR-guided targeting and real-time visualization via fluorescence signals.

The prominent product types of clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays include kits, reagents, instruments, and other variants. Kits are ready-to-use assemblies containing all necessary materials for CRISPR-based fluorescence detection experiments. They include Cas9-based, Cas12-based, Cas13-based assays, and others, with fluorescence-based and lateral flow detection methods. Applications include gene editing, diagnostics, drug discovery, and others, serving academic and research institutes, pharmaceutical and biotechnology companies, clinical laboratories, and other end-users.

Tariffs on imported CRISPR reagents, fluorescent probes, and molecular biology instruments are impacting the CRISPR fluorescence assay market by increasing costs for kits, reagents, and instruments, particularly affecting Cas12, Cas13, and multiplex assay segments. Regions such as North America, Europe, and Asia-Pacific that rely on imported enzymes and fluorescence readers are most affected. While tariffs elevate costs, they encourage domestic manufacturing, local reagent production, and innovation in cost-effective assay platforms, fostering long-term regional market resilience.

The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market research report is one of a series of new reports from The Business Research Company that provides clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market statistics, including clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays industry global market size, regional shares, competitors with a clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market share, detailed clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market segments, market trends and opportunities, and any further data you may need to thrive in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays industry. This clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market size has grown rapidly in recent years. It will grow from $1.57 billion in 2025 to $1.87 billion in 2026 at a compound annual growth rate (CAGR) of 19.3%. The growth in the historic period can be attributed to rising demand for rapid molecular diagnostics, adoption of cas9-based detection tools, growth of academic and research institutes, expansion of pharmaceutical and biotechnology research, increasing prevalence of genetic research initiatives.

The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market size is expected to see rapid growth in the next few years. It will grow to $3.83 billion in 2030 at a compound annual growth rate (CAGR) of 19.5%. The growth in the forecast period can be attributed to growing adoption of multiplex and high-throughput assays, increasing integration with ai-enabled analysis platforms, rising demand for point-of-care diagnostics, expansion of clinical laboratory capabilities, increasing focus on personalized medicine applications. Major trends in the forecast period include increasing adoption of multiplex crispr fluorescence assays, rising demand for cas12 and cas13-based detection technologies, growing integration of real-time fluorescence readers, expansion of diagnostic and drug discovery applications, rising focus on high-sensitivity pathogen and biomarker detection.

The increasing preference for personalized medicine is anticipated to drive the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market in the coming years. Personalized medicine involves customizing medical treatment and preventive strategies according to an individual's genetic makeup, environmental factors, and lifestyle characteristics to achieve maximum effectiveness. The expansion of personalized medicine is fueled by the growing incidence of chronic diseases, which demand targeted therapies that deliver better outcomes for individual patients compared to conventional treatments. CRISPR fluorescence assays support personalized medicine by facilitating rapid and highly specific identification of genetic mutations or biomarkers within a patient's DNA, enabling physicians to detect disease-causing variants and customize treatments based on the patient's unique genetic profile. For example, in February 2024, as reported by the Personalized Medicine Coalition, a US-based non-profit organization, the FDA approved 16 new personalized therapies for rare disease patients in 2023, an increase from six approvals in 2022. Consequently, the growing preference for personalized medicine is contributing to the expansion of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market.

The increasing research and development activities are projected to accelerate the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market in the future. Research and development (R&D) activities encompass the creation and evaluation of new knowledge, products, or processes aimed at fostering innovation and business advancement. These activities are expanding as companies strive to achieve growth and maintain a competitive edge through the development of new and enhanced products or technologies. Research and development initiatives bolster CRISPR fluorescence assays by enhancing assay technologies, refining detection accuracy, and developing innovative solutions for genetic analysis and targeted therapeutic applications. For instance, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government's net expenditure on research and development (R&D) rose to £17.4 billion ($22.1 billion) in 2023 from £16.1 billion ($20.45 billion) in 2022, representing an 8.2% increase. Therefore, the growing emphasis on research and development activities is driving the growth of the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market.

In December 2024, OraSure Technologies Inc., a US-based medical device company, acquired Sherlock Biosciences Inc. for an undisclosed amount. Through this acquisition, OraSure intends to broaden its infectious disease testing portfolio by integrating Sherlock's CRISPR-Cas13 diagnostic platforms and fluorescence-based CRISPR detection technology to advance next-generation molecular diagnostics. Sherlock Biosciences Inc. is a US-based biotechnology company that provides CRISPR-based diagnostic assays utilizing fluorescence detection.

Major companies operating in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market are Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific SE, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Ginkgo Bioworks, OriGene Technologies Inc., Synthego Corporation, Inscripta Inc., Mammoth Biosciences Inc., Creative Biolabs, Cellecta Inc., GeneCopoeia Inc., SBS Genetech Co. Ltd., Addgene, CrisprBits Private Limited.

North America was the largest region in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market includes revenues earned by entities providing services such as pathogen detection, genetic mutation screening, and gene expression analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The clustered regularly interspaced short palindromic repeats (CRISPR) fluorescence assays market includes sales of CRISPR-based detection kits, reagents, Cas enzymes, fluorescent reporters, and assay consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses clustered regularly interspaced short palindromic repeats (crispr) fluorescence assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clustered regularly interspaced short palindromic repeats (crispr) fluorescence assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clustered regularly interspaced short palindromic repeats (crispr) fluorescence assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Kits; Reagents; Instruments; Other Product Types
  • 2) By Technology: Cas9-Based Fluorescence Assays; Cas12-Based Fluorescence Assays; Cas13-Based Assays; Other Technologies
  • 3) By Detection: Fluorescence-Based; Lateral Flow
  • 4) By Application: Gene Editing; Diagnostics; Drug Discovery; Other Applications
  • 5) By End-User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories; Other End-Users
  • Subsegments:
  • 1) By Kits: Detection Kits; Editing Kits; Multiplex Kits
  • 2) By Reagents: Cas Enzymes; Buffers And Solutions; Probes And Reporters
  • 3) By Instruments: Fluorescence Readers; Real-Time PCR Instruments; Microplate Readers
  • 4) By Other Product Types: Consumables; Accessories; Software
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Merck KGaA; Eurofins Scientific SE; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Integrated DNA Technologies Inc.; GenScript Biotech Corporation; Takara Bio Inc.; Ginkgo Bioworks; OriGene Technologies Inc.; Synthego Corporation; Inscripta Inc.; Mammoth Biosciences Inc.; Creative Biolabs; Cellecta Inc.; GeneCopoeia Inc.; SBS Genetech Co. Ltd.; Addgene; CrisprBits Private Limited.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption of Multiplex CRISPR Fluorescence Assays
    • 4.2.2 Rising Demand for Cas12 and Cas13-Based Detection Technologies
    • 4.2.3 Growing Integration of Real-Time Fluorescence Readers
    • 4.2.4 Expansion of Diagnostic and Drug Discovery Applications
    • 4.2.5 Rising Focus on High-Sensitivity Pathogen and Biomarker Detection

5. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Analysis Of End Use Industries

  • 5.1 Academic And Research Institutes
  • 5.2 Pharmaceutical And Biotechnology Companies
  • 5.3 Clinical Laboratories
  • 5.4 Contract Research Organizations
  • 5.5 Diagnostic And Testing Centers

6. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Segmentation

  • 9.1. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kits, Reagents, Instruments, Other Product Types
  • 9.2. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cas9-Based Fluorescence Assays, Cas12-Based Fluorescence Assays, Cas13-Based Assays, Other Technologies
  • 9.3. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescence-Based, Lateral Flow
  • 9.4. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gene Editing, Diagnostics, Drug Discovery, Other Applications
  • 9.5. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Clinical Laboratories, Other End-Users
  • 9.6. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Detection Kits, Editing Kits, Multiplex Kits
  • 9.7. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Sub-Segmentation Of Reagents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cas Enzymes, Buffers And Solutions, Probes And Reporters
  • 9.8. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Fluorescence Readers, Real-Time PCR Instruments, Microplate Readers
  • 9.9. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consumables, Accessories, Software

10. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Regional And Country Analysis

  • 10.1. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 11.1. Asia-Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 12.1. China Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 13.1. India Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 14.1. Japan Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 15.1. Australia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 16.1. Indonesia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 17.1. South Korea Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 18.1. Taiwan Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 19.1. South East Asia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 20.1. Western Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 21.1. UK Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 22.1. Germany Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 23.1. France Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 24.1. Italy Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 25.1. Spain Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 26.1. Eastern Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 27.1. Russia Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 28.1. North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 29.1. USA Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 30.1. Canada Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 31.1. South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 32.1. Brazil Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 33.1. Middle East Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

  • 34.1. Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Detection, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Regulatory and Investment Landscape

36. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Competitive Landscape And Company Profiles

  • 36.1. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Bio-Rad Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Other Major And Innovative Companies

  • QIAGEN N.V., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Ginkgo Bioworks, OriGene Technologies Inc., Synthego Corporation, Inscripta Inc., Mammoth Biosciences Inc., Creative Biolabs, Cellecta Inc., GeneCopoeia Inc., SBS Genetech Co. Ltd., Addgene, CrisprBits Private Limited

38. Global Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market

41. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market High Potential Countries, Segments and Strategies

  • 41.1 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Fluorescence Assays Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기